Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiang Qu

Showing results (151-160 of 324) with videos related to

Pageof 33
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 1, 2020
Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-AnalysisXiao-Dong Zheng, Qiang Qu, Xing-Yu Jiang, et al.
Clinical & Experimental Ophthalmology|March 3, 2018
Clinical outcomes after Descemet's stripping endothelial keratoplasty using donor corneas from children younger than 3 yearsRong-Mei Peng, Yu-Xin Guo, Yuan Qiu, et al.
Cancer Drug Resistance (Alhambra, Calif.)|August 22, 2025
Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expressionXinqi Teng, Yiming Wang, Qiang Qu, et al.
Mediators of Inflammation|December 23, 2020
Neutrophil-Lymphocyte Ratio in Predicting Infective Endocarditis: A Case-Control Retrospective StudyYing Chen, Liang-Jun Ye, Yue Wu, et al.
Pathology, Research and Practice|May 31, 2017
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasioLi Zhou, Jing-An Rui, Wei-Xun Zhou, et al.
Frontiers in Pharmacology|August 14, 2023
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancerZhen-Chu Tang, Qiang Qu, Xin-Qi Teng, et al.
Frontiers in Pharmacology|September 22, 2023
Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancerZhen-Chu Tang, Qiang Qu, Xin-Qi Teng, et al.
Journal of Oncology|March 10, 2021
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective StudyJianchun Xiao, Li Wang, Tao Hong, et al.
Frontiers in Pharmacology|July 23, 2016
Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα PathwayJian Luo, Jian Qu, Rui Yang, et al.
Infection and Drug Resistance|March 29, 2022
Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and SafetyJian Qu, Ting-Ting Qi, Qiang Qu, et al.
Pageof 33

Showing results (151-160 of 324) with videos related to

Sort By:
Pageof 33
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 1, 2020
Effects of Dapagliflozin on Cardiovascular Events, Death, and Safety Outcomes in Patients with Heart Failure: A Meta-AnalysisXiao-Dong Zheng, Qiang Qu, Xing-Yu Jiang, et al.
Clinical & Experimental Ophthalmology|March 3, 2018
Clinical outcomes after Descemet's stripping endothelial keratoplasty using donor corneas from children younger than 3 yearsRong-Mei Peng, Yu-Xin Guo, Yuan Qiu, et al.
Cancer Drug Resistance (Alhambra, Calif.)|August 22, 2025
Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expressionXinqi Teng, Yiming Wang, Qiang Qu, et al.
Mediators of Inflammation|December 23, 2020
Neutrophil-Lymphocyte Ratio in Predicting Infective Endocarditis: A Case-Control Retrospective StudyYing Chen, Liang-Jun Ye, Yue Wu, et al.
Pathology, Research and Practice|May 31, 2017
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasioLi Zhou, Jing-An Rui, Wei-Xun Zhou, et al.
Frontiers in Pharmacology|August 14, 2023
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancerZhen-Chu Tang, Qiang Qu, Xin-Qi Teng, et al.
Frontiers in Pharmacology|September 22, 2023
Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancerZhen-Chu Tang, Qiang Qu, Xin-Qi Teng, et al.
Journal of Oncology|March 10, 2021
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective StudyJianchun Xiao, Li Wang, Tao Hong, et al.
Frontiers in Pharmacology|July 23, 2016
Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα PathwayJian Luo, Jian Qu, Rui Yang, et al.
Infection and Drug Resistance|March 29, 2022
Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and SafetyJian Qu, Ting-Ting Qi, Qiang Qu, et al.
Pageof 33